Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
63.61
-0.74 (-1.15%)
Sep 8, 2025, 2:45 PM CST
SHE:300049 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 89.86 | 113.29 | 101.56 | 97.89 | 95.47 | 61.91 | Upgrade |
Depreciation & Amortization | 95.79 | 91.12 | 80.9 | 72.39 | 67.05 | 69.35 | Upgrade |
Other Amortization | 3.58 | 3.99 | 9.32 | 3.92 | 1.17 | 1.55 | Upgrade |
Loss (Gain) From Sale of Assets | -0.07 | 0.31 | 0.82 | 1.86 | 3.46 | 6.93 | Upgrade |
Asset Writedown & Restructuring Costs | 3.7 | 7.7 | 4.71 | 0 | - | 3.35 | Upgrade |
Loss (Gain) From Sale of Investments | 25.03 | 23.11 | -2.53 | -4.12 | -5.74 | 1.6 | Upgrade |
Provision & Write-off of Bad Debts | 24.13 | 19.79 | 1.55 | 6.58 | 8.95 | 1.83 | Upgrade |
Other Operating Activities | 96.85 | 78.44 | 71.84 | 49.1 | 54.9 | 31.57 | Upgrade |
Change in Accounts Receivable | -132.25 | -106.26 | -24.6 | -94.93 | -85 | 45.69 | Upgrade |
Change in Inventory | -28.96 | -38.15 | -4.62 | -3.09 | 4.17 | 11.02 | Upgrade |
Change in Accounts Payable | 65.29 | 18.13 | 68.82 | 66.76 | 57.31 | -28.99 | Upgrade |
Change in Other Net Operating Assets | 15.38 | 19.42 | - | - | - | - | Upgrade |
Operating Cash Flow | 251.2 | 221.41 | 304.89 | 189.46 | 222.55 | 200.15 | Upgrade |
Operating Cash Flow Growth | -13.22% | -27.38% | 60.92% | -14.87% | 11.19% | -21.88% | Upgrade |
Capital Expenditures | -241.21 | -218.97 | -189.23 | -90.78 | -79.61 | -109.74 | Upgrade |
Sale of Property, Plant & Equipment | 4.59 | 4.97 | 2.73 | 1.86 | 2.01 | 2.67 | Upgrade |
Cash Acquisitions | 18.75 | 18.75 | 0.95 | 0.62 | -0.12 | - | Upgrade |
Divestitures | - | - | 0.83 | - | - | 0.7 | Upgrade |
Investment in Securities | -150.51 | -120.07 | -7.01 | 2.84 | -116.28 | 68.74 | Upgrade |
Other Investing Activities | -44.75 | 8.93 | 41.3 | 17.01 | 11.44 | 5.56 | Upgrade |
Investing Cash Flow | -413.13 | -306.38 | -150.43 | -68.45 | -182.56 | -32.07 | Upgrade |
Short-Term Debt Issued | - | 21.67 | 16.33 | 2.81 | 47.97 | 115.32 | Upgrade |
Total Debt Issued | 22.31 | 21.67 | 16.33 | 2.81 | 47.97 | 115.32 | Upgrade |
Short-Term Debt Repaid | - | - | -11.99 | -51.13 | -69.89 | -109.54 | Upgrade |
Long-Term Debt Repaid | - | -19.72 | -9.5 | -11.36 | -14.24 | - | Upgrade |
Total Debt Repaid | -12.12 | -19.72 | -21.49 | -62.49 | -84.13 | -109.54 | Upgrade |
Net Debt Issued (Repaid) | 10.19 | 1.95 | -5.16 | -59.68 | -36.16 | 5.77 | Upgrade |
Issuance of Common Stock | 184.16 | 183.05 | - | - | 26.6 | 0.2 | Upgrade |
Repurchase of Common Stock | -4.07 | -4.07 | - | - | - | - | Upgrade |
Common Dividends Paid | -2.08 | -2.2 | -53.42 | -71.41 | -1.95 | -3.76 | Upgrade |
Other Financing Activities | -72.13 | -40.21 | -78.57 | 4.56 | 4.85 | -0.82 | Upgrade |
Financing Cash Flow | 116.08 | 138.52 | -137.14 | -126.54 | -6.65 | 1.4 | Upgrade |
Foreign Exchange Rate Adjustments | 19.76 | -3.35 | 13.06 | 12.01 | -28.52 | -0.66 | Upgrade |
Net Cash Flow | -26.1 | 50.2 | 30.38 | 6.49 | 4.82 | 168.83 | Upgrade |
Free Cash Flow | 9.98 | 2.44 | 115.66 | 98.69 | 142.94 | 90.41 | Upgrade |
Free Cash Flow Growth | -88.29% | -97.89% | 17.20% | -30.96% | 58.11% | -52.40% | Upgrade |
Free Cash Flow Margin | 0.70% | 0.18% | 10.03% | 9.78% | 15.91% | 11.20% | Upgrade |
Free Cash Flow Per Share | 0.04 | 0.01 | 0.44 | 0.38 | 0.55 | 0.35 | Upgrade |
Cash Income Tax Paid | 63.82 | 122.56 | 102.31 | 89.39 | 52.05 | 86.11 | Upgrade |
Levered Free Cash Flow | -18.59 | -17.26 | 61.06 | 34.29 | 102.67 | 63.17 | Upgrade |
Unlevered Free Cash Flow | -16.73 | -15.53 | 61.62 | 35.28 | 104.12 | 65.18 | Upgrade |
Change in Working Capital | -87.67 | -116.33 | 36.73 | -38.17 | -2.71 | 22.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.